tyrphostin ag 1024 has been researched along with Schistosomiasis mansoni in 1 studies
tyrphostin AG 1024: modulates radiosensitivity in human breast cancer cells; also an IGF1 receptor inhibitor
Schistosomiasis mansoni: Schistosomiasis caused by Schistosoma mansoni. It is endemic in Africa, the Middle East, South America, and the Caribbean and affects mainly the bowel, spleen, and liver.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elhenawy, AA | 1 |
| Ashour, RH | 1 |
| Nabih, N | 1 |
| Shalaby, NM | 1 |
| El-Karef, AA | 1 |
| Abou-El-Wafa, HS | 1 |
1 other study available for tyrphostin ag 1024 and Schistosomiasis mansoni
| Article | Year |
|---|---|
Insulin growth factor inhibitor as a potential new anti-schistosoma drug: An in vivo experimental study.
Topics: Animals; Antigens, Helminth; Body Weight; Female; Glucose Transporter Type 4; Homeostasis; Insulin R | 2017 |